A U.S. Patent Application for “Methods for Continuously Inactivating a Virus During Manufacture of a Protein” was published by Boehringer Ingelheim on March 7th, 2019. The present invention refers to methods for continuously inactivating a virus during manufacture of a protein are provided. Steps include (1) combining, at a single predetermined volumetric ratio, a composition including the protein, and a composition including a virus-inactivation reagent, to obtain a treatment composition having a predetermined property for inactivation of a virus; (2) transferring the treatment composition to a treatment vessel; (3) incubating the treatment composition in the treatment vessel at predetermined conditions… Learn More